financetom
Business
financetom
/
Business
/
Taseko Mines Posts Increase In Q4 Adjusted Net Income YOY
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taseko Mines Posts Increase In Q4 Adjusted Net Income YOY
Mar 8, 2024 3:54 AM

06:27 AM EST, 03/08/2024 (MT Newswires) -- Taseko Mines Limited ( TGB ) overnight Thursday reported fourth-quarter 2023 adjusted net income of $24.1 million, or $0.08 per share, rising from $7.1 million, or $0.02 per share, in the year-ago quarter.

Revenues also rose to $153.7 million from $100.6 million in the prior-year quarter.

Adjusted EBITDA increased to $69.1 million from $35.2 million in the same quarter a year ago.

Fourth-quarter copper production from the Gibraltar mine was 34 million pounds. Annual production of 123 million pounds in 2023 was above the company's original guidance and 26% higher than in 2022, Taseko said.

Taseko's strategy has been to acquire and develop a pipeline of complementary projects focus on copper in stable mining jurisdictions.

The company is preparing to advance the Yellowhead copper project into the environmental assessment process and is undertaking additional engineering work.

Taseko is still in talks with the Tsilhqot'in Nation to resolve conflict regarding the company's proposed copper-gold mine previously known as New Prosperity. The parties in March formally reinstated a standstill agreement for a final term, with a goal of finalizing a resolution before year-end.

Environmental monitoring and product marketing initiatives on the Aley niobium project continue. The converter pilot test is ongoing and is providing additional process data to support the design of the commercial process facilities and will provide final product samples for marketing purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Trilogy Metals Jumps 11% as Notes Issuance of Right-of-Way Permits for Ambler Access Project in Alaska
Update: Trilogy Metals Jumps 11% as Notes Issuance of Right-of-Way Permits for Ambler Access Project in Alaska
Oct 24, 2025
11:26 AM EDT, 10/24/2025 (MT Newswires) -- Trilogy Metals ( TMQ ) Friday provided an update on the Ambler Access Project that would enable the development of the Ambler Mining District in Alaska. The Alaska Industrial Development and Export Authority (AIDEA), which manages the project, has executed the right-of-way permits for the project with the U.S. Army Corps of Engineers,...
Amazon Likely to Post Strong Q3 on AWS Growth, Healthy Retail Trends, Wedbush Says
Amazon Likely to Post Strong Q3 on AWS Growth, Healthy Retail Trends, Wedbush Says
Oct 24, 2025
11:27 AM EDT, 10/24/2025 (MT Newswires) -- Amazon.com's ( AMZN ) Q3 results are likely to reflect Amazon Web Services momentum, strong advertiser demand, and healthy retail trends, supported by continued fulfillment optimization and a shift to higher-margin businesses, Wedbush said in a note Friday. Amazon's ( AMZN ) growth may accelerate further, driven by artificial intelligence monetization, automation gains,...
SLM Expected to Unveil 'Capital-Light' Private Credit Partnership Over Next Months, Morgan Stanley Says
SLM Expected to Unveil 'Capital-Light' Private Credit Partnership Over Next Months, Morgan Stanley Says
Oct 24, 2025
11:26 AM EDT, 10/24/2025 (MT Newswires) -- SLM (SLM) is moving closer to unveiling a new capital-light private credit partnership that could help stabilize long-term cash flow, Morgan Stanley said Friday. The investment firm said the partnership is expected to be announced within one to two months and discussed in detail at SLM's December investor forum. While the arrangement is...
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics
Oct 24, 2025
SAN DIEGO, Oct. 24, 2025 /PRNewswire/ -- ChemDiv, a global provider of integrated drug discovery solutions, today announced that it will continue providing chemistry, computational, and clinical pharmacology support to Clywedog Therapeutics as the company enters into a definitive merger agreement with Barinthus Therapeutics . The combined entity will operate under the name Clywedog Therapeutics, Inc. and is expected to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved